The Whipple Disease (WD) is an extremely rare infective condition with an incidence of one individual in a million people1, mainly attributed to the Tropherima Whipplei (TW). It is described as a gram-positive belonging to the family of Actinomycetes.Along with other factors, the genetic plays its role through the immunological hyperactivity towards TW. Here we report an atypical presentation of this disease, in a patient admitted to our Department several times. Male patient, 46 years old, affected by essential epilepsy, treated with Carbamazepine, and a serum-negative rheumatoid arthritis treated with NSAID. The patient reported a right-sided hearing loss due to suspected viral infection and had a history of papillary thyroid carcinoma, treated with a total thyroidectomy and radiometabolic therapy. The patient was hospitalized to our Nephrology Unit for the onset of a nephrotic syndrome (24h-proteinuria 13640 mg/day) and US-guided renal biopsy was performed, where leading to a histological diagnosis of Membranous Nephropathy (MN) with high titre of serum PLA2R antibodies and normal kidney function (Tab.1). Because of his personal history of neoplasia, we could not follow KDIGO guidelines recommendations for MN, which indicate a first-line treatment with an alkylating agent alternated with cortisone for six months2.Therefore we opted for a treatment with mycophenolate of 2g/die. Due to the failed remission, we started a treatment with Rituximab.The patient has been hospitalized three more times for the onset of dyspepsia, anaemia, joint pain, weight loss, diarrhea and fever, which have been studied by the following examinations (Tab. 2). In particular, a diffuse lymphangiectasia was highlighted at the second esophagogastroduodenoscopy (EGD) performed (Fig. 1). The last EGD revealed a flocculating appearance of the second duodenal portion mucosa, resembling grain of millet. The histological examination noted the presence of massive macrophage infiltration and a slight shortening of the villi. The pictures were perfectly compatible with the diagnosis of WD (Fig 2.). The patient undertook antibiotic therapy with doxycycline 200 mg/day in combination with hydroxychloroquine 600 mg/day with a maintenance dosage of prednisone 5 mg/day. After two months, he reached the complete remission of joint and gastrointestinal manifestations with improvement of renal parameters: albuminemia raised of 13% (2.75 mg/dl), and 24h-proteinuria reduced of 60% (3596 mg). The WD diagnosis and the response to the therapy clarified the pathogenesis of other symptoms previously attributed to other idiopathic different diseases. Therefore, we assume that these manifestations may be caused by the overlapping action of the autoimmune renal pathology and WD.
Read full abstract